Investment Funding
The Life Sciences Practice assists biotechnology and pharmaceutical enterprises
in developing funding strategies to capitalize their businesses and the commercialization
process. Life Sciences attorneys work closely with Spencer Fane's Business
Transactions Practice which serves clients ranging in size from small start-up
entities to very large public companies. Our attorneys provide general business
counsel and advise clients related to company formation, corporate governance,
debt and equity financing, securities, mergers and acquisitions, executive employment
agreements, regulatory matters, partnerships and joint ventures, and taxation.
Our experience also includes conducting intellectual property due diligence
as a part of initial public offerings (IPOs), private placements, mergers, acquisitions,
and spin-outs.
We also represent lenders, borrowers, investors and life sciences growth companies
in structuring, negotiating and closing a wide variety of financing and capital
formation transactions, including senior term and revolving credit facilities,
subordinated debt, convertible debt, venture and private equity financing, and
restructurings. Our experience includes working directly with investors in preparing:
- legal opinions including patentability, infringement, validity and freedom-to-operate
opinions
- patent portfolio audits
- patent landscape analyses
- technology clearance studies
The Life Sciences Practice has also assisted its clients in identifying potential
sources of capital, and in determining what technologies may be over- or under-invested,
current market conditions, and in developing venture management strategies.
By doing so, the information our clients obtain from angel, corporate and venture
capital investors can be leveraged to more effectively develop intellectual
property strategies that protect "investable" aspects of a technology.
No matter what your financial position may be, Spencer Fane attorneys are able
to assist in capitalizing the research and development of life sciences technologies.